Unitree's Shanghai Debut: A 629% First-Day Pop for China's First Humanoid-Robotics Listing
Unitree Robotics shares opened at 1,100 yuan on the Shanghai STAR Market on August 19, 2026, a 629% jump from the IPO price of 150.80 yuan ($22.34). The opening price valued the Hangzhou-based humanoid-robotics firm at far more than the roughly 61 billion yuan ($9 billion) implied at the offering price. Reuters
Unitree, officially known as Yushu Technology, raised about 6.1 billion yuan (around $905 million) by selling 10% of its enlarged capital. The IPO was priced on August 6 at 150.8 yuan per share, according to CNBC. The offering was sponsored by Citic Securities, which reportedly projected a post-IPO valuation above 50 billion yuan. CNBC
The company is the first humanoid-robotics firm to list on mainland China's stock market, according to the Wall Street Journal. The Shanghai Stock Exchange's listing committee approved Unitree's STAR Market application in early June 2026, after scheduling the review in late May. WSJ SSE
Unitree's IPO prospectus, filed with the Shanghai bourse, reports cumulative sales of 33,294 quadruped robots (four-legged, dog-like machines) and 5,632 humanoid robots across 2023 to 2025. Of that humanoid figure, the company shipped more than 5,500 units in 2025 alone, which it ranks as No. 1 globally. The prospectus also references a partnership with Nvidia on robotics systems, announced at the same time as the June listing approval. SSE SSE SSE
On the product side, Unitree's G1 humanoid robot AI agent starts at $13,500, while its Go2 quadruped robot is equipped with 4D ultra-wide-angle LiDAR — a sensing technology that uses laser pulses to map surroundings in three dimensions. Unitree G1 Unitree Go2
The first-day surge places Unitree in the upper range of STAR Market debuts. The STAR Market, China's tech-focused board, applies a 20% daily price band for regular trading, meaning a stock can rise or fall at most 20% in a single day. But newly listed shares are exempt from that cap on their first day, so the opening price is set by open-market buying and selling with no ceiling.
At the opening price of 1,100 yuan, the 10% of shares sold in the IPO implies a total market capitalization above 366 billion yuan — roughly six times the valuation implied at the offering price. Whether that level holds under the 20% daily limit in the days ahead will depend on how well the market absorbs the available shares, how much institutional money participates, and how strong retail demand is for a pure-play humanoid-robotics stock in a market with few direct peers.
The broader context here is that Unitree's listing arrives as humanoid-robotics companies globally are seeking public capital to scale from R&D-stage production toward commercial deployment. The STAR Market's listing criteria emphasize technological innovation over profitability, which has created a pathway for pre-profit or early-revenue hardware companies to go public. That structural feature means investors are effectively betting on future commercialization rather than current earnings, with all the uncertainty that entails.
For market participants, the key variables to watch are first-week price discovery under the daily band, the lock-up schedule for the 90% of shares not sold in the offering, and any follow-on disclosure about Nvidia partnership revenue or product integration milestones. The Nvidia partnership and the No. 1 global shipment claim for 2025 are the two fundamentals investors are weighing against that valuation. Shipped volume of 5,500-plus humanoid units is a real production figure, but the revenue and profit margin behind those sales is what the prospectus will need to hold up under sustained scrutiny. The G1's $13,500 entry price gives a reference point for unit economics, but the gap between selling thousands of robots and justifying a multi-hundred-billion-yuan market cap is the central question the secondary market will now test.
In my view, the gap between the offering valuation and the opening-market valuation is, at this stage, a measure of demand for access to a scarce equity instrument, not necessarily a statement about the durability of the underlying business.
